尽管采用规模扩大，美国制药高管仍对人工智能在药物成功方面的影响持谨慎态度

本文如何被排名

Signal score

5 / 100

Composite score across the factors below. Higher = stronger signal that this story matters right now.

Newsworthiness bucket

Commentary

文章讨论了制药行业对人工智能的采用趋势和高管情绪，而非具体事件。

Source corroboration

Single-source cluster

Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.

Topics

product, policy

Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.

AI-industry relevance

Standard

On-topic for AI-industry coverage; kept in the public index.

Story freshness

Breaking (< 6h)

Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。